The use of interferon α in Behçet disease: Review of the literatureKÖTTER, Ina; GÜNAYDIN, Ilhan; ZIERHUT, Manfred et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 5, pp 320-335, issn 0049-0172, 16 p.Article

Morbus Behçet: Uveitis-therapie mit interferon α2a - prospektive klinische (Pilot-)Studie an 33 Patienten = Behçet's disease: uveitis-therapy with interferon α2a: prospective clinical study in 33 patientsSTÜBIGER, Nicole; KÖTTER, Ina; DEUTER, Christoph et al.Klinische Monatsblätter für Augenheilkunde. 2001, Vol 218, Num 12, pp 768-773, issn 0023-2165Article

Long-Term Remission After Cessation of Interferon-α Treatment in Patients With Severe Uveitis Due to Behçet's DiseaseDEUTER, Christoph M. E; ZIERHUT, Manfred; MÖHLE, Antje et al.Arthritis and rheumatism. 2010, Vol 62, Num 9, pp 2796-2805, issn 0004-3591, 10 p.Article

Erste klinische Erfahrungen mit Mycophenolatmofetil bei der immunsuppressiven Therapie des okulären Pemphigoids = Early clinical experiences with mycophenolate mofetil for immunosuppressive therapy of ocular cicatrical pemphigoldZURDEL, Jan; ABOALCHAMAT, Bilal; ZIERHUT, Manfred et al.Klinische Monatsblätter für Augenheilkunde. 2001, Vol 218, Num 4, pp 222-228, issn 0023-2165Article

Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of Behçet disease: Results of an open 4-center trialKÖTTER, Ina; VONTHEIN, Reinhard; ZIERHUT, Manfred et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 5, pp 311-319, issn 0049-0172, 9 p.Article